Revenue Performance - Revenue for Q1 FY25 was 14.5billion,a4.014,531.7 million, an increase of 4.0% from 13,975.3millioninQ1FY24[34]−TDSYNNEXreportedrevenueof14,531.7 million for the three months ended February 28, 2025, an increase of 4% compared to 13,975.3millionforthesameperiodin2024[28]−TheAmericasregiongenerated8.4 billion in revenue, a 6.2% increase from the prior fiscal first quarter[7] - The Europe region reported revenue of 5.1billion,a0.41.0 billion, a 5.2% increase compared to the prior fiscal first quarter[11] Earnings and Income - Diluted EPS for Q1 FY25 was 1.98,a2.61.93 in Q1 FY24[4] - The company's net income for the same period was 167.5million,slightlydownfrom172.1 million year-over-year[28] - Non-GAAP net income for the three months ended February 28, 2025, was 237,371thousand,adecreaseof10.8266,223 thousand for the same period in 2024[44] - Non-GAAP diluted EPS for the three months ended February 28, 2025, was 2.80,down6.42.99 in the prior year[44] Operating Performance - Operating income was 304.5million,aslightincreaseof0.6302.6 million in the prior year[3] - Operating income for the trailing fiscal four quarters was 1,196,098thousand,anincreaseof10.51,082,442 thousand in the previous year[48] - Non-GAAP operating income for the consolidated entity was 398.8million,adecreasefrom424.6 million in the prior year[40] - Non-GAAP operating margin for consolidated operations was 2.74%, down from 3.04% in Q1 FY24[40] Cash Flow and Liquidity - Cash used in operations was 748million,comparedtocashprovidedbyoperationsof385 million in the prior fiscal first quarter[7] - Free cash flow was negative at (748.0)millionforthethreemonthsendedFebruary28,2025,comparedtopositivecashflowof384.7 million for the same period in 2024[30] - Free cash flow for the three months ended February 28, 2025, was (789,522)thousand,comparedto343,621 thousand in the same period last year[46] - The cash conversion cycle increased to 27 days for the three months ended February 28, 2025, compared to 21 days in the same period last year[50] Forecast and Guidance - For Q2 FY25, the company expects revenue between 13.9billionand14.7 billion, with non-GAAP gross billings projected at 19.7billionto20.7 billion[8] - The forecast for non-GAAP net income for the three months ending May 31, 2025, ranges from 205millionto247 million[46] - The forecasted non-GAAP gross billings for the three months ending May 31, 2025, is expected to be between 19.7billionand20.7 billion[46] Asset and Liability Management - Total current assets decreased to 19,958.9millionasofFebruary28,2025,from21,324.7 million as of November 30, 2024[26] - Total liabilities decreased to 20,745.7millionasofFebruary28,2025,from22,239.0 million as of November 30, 2024[26] - The company’s cash and cash equivalents decreased to 541.9millionasofFebruary28,2025,from1,059.4 million as of November 30, 2024[26] Segment Performance - Operating income for the Americas segment increased by 21.3% to 193.7million,comparedto159.7 million in Q1 FY24[32] - Revenue in the Americas was 8,389.3million,reflectinga6.27,903.1 million in Q1 FY24[32] - Europe segment revenue slightly increased by 0.4% to 5,137.8million,whileoperatingincomedecreasedby20.785.9 million[32] - Asia-Pacific and Japan revenue grew by 5.2% to 1,004.6million,butoperatingincomefellby28.324.8 million[32] Other Financial Metrics - Non-GAAP gross billings reached 20.7billion,up7.520,718.2 million, up 7.5% from 19,266.7millioninthepreviousyear[36]−Adjustedselling,generalandadministrativeexpensesasapercentageofrevenuedecreasedto4.77283.7 million to consolidated revenue[34] - Days inventory outstanding increased to 56 days for the three months ended February 28, 2025, compared to 50 days in the prior year[50] Management Insights - TD SYNNEX management emphasizes the importance of non-GAAP financial measures for understanding operational results and trends[20] - The company incurred acquisition, integration, and restructuring costs of 1.1millionforthethreemonthsendedFebruary28,2025,downfrom31.6 million in the prior year[28] - Share-based compensation expense for the three months ended February 28, 2025, was 21.9million,comparedto17.5 million for the same period in 2024[30] - Return on Invested Capital (ROIC) improved to 8.4% for the three months ended February 28, 2025, compared to 7.5% in the prior year[48]